News, Analysis & Insights on Nutrition, Supplements, and Health
The Food and Drug Administration has overstepped its bounds by ruling that a study’s endpoints, rather than the intended use of the product or ingredient being studies, determines whether an Investigational New Drug application must be filed in the...
ASA ruling
The UK’s advertising watchdog has lambasted Slenderiiz UK for making insufficiently robust medicinal and weight loss claims on its website for its herbal homeopathic supplements - Slenderiix Drops and Xceler8 Drops.
News in brief
Kyowa Hakko USA has announced that its Setria glutathione ingredient meets the US Pharmacopeial Convention (USP) monograph for the ingredient, raising awareness of the quality and purity of the ingredient.
DSM’s consumer products division i-Health has settled a claim with the Federal Trade Commission on the company’s use of an adult memory-enhancement claim for its algal DHA product.
French supplier Roquette has advanced its commitment to the chlorella and algae extract market by inaugurating a 4-5000 tonne a year chlorella facility at its HQ near Lille in northern France, as chlorella continues to move from the shadow of spirulina.
DSM will market its OatWell beta-glucan ingredient direct to the public in its first ever direct-to-consumer product ranges.
Michael Nuzzo, executive VP and CFO of GNC Holdings, Inc., has tendered his resignation in order to accept an executive position at a private equity funded consumer products company.
With a newly constructed plant in Sherbrooke, Québec, now open, three new products launching, and the IP wars behind it, krill oil pioneer Neptune Technologies & Bioressources is in a ‘strong position’ moving forward, the company’s senior vice president...